Evidence map›Paper›PMID 31614900›Full record

ArticleInternational journal of molecular sciences2019

Thrombin Upregulates PAI-1 and Mesothelial-Mesenchymal Transition Through PAR-1 and Contributes to Tuberculous Pleural Fibrosis.

Cheng-Ying Hsieh, Joen-Rong Sheu, Chih-Hao Yang, Wei-Lin Chen, Jie-Heng Tsai, Chi-Li Chung

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Update on Novel Targeted Therapy for Pleural Organization and Fibrosis.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Cheng-Ying HsiehDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. hsiehcy@tmu.edu.tw.
Joen-Rong SheuDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. sheujr@tmu.edu.tw.ORCID 0000-0001-8265-3678
Chih-Hao YangDepartment of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan. chyang@tmu.edu.tw.
Wei-Lin ChenDepartment of Nursing, Mackay Junior College of Medicine, Nursing, and Management, Taipei 112, Taiwan. s519@mail.mkc.edu.tw.
Jie-Heng TsaiSchool of Nutrition and Health Sciences, College of Public Health and Nutrition, Taipei Medical University, Taipei 110, Taiwan. a19851102@hotmail.com.
Chi-Li ChungDivision of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 110, Taiwan. clchung@tmu.edu.tw.ORCID 0000-0003-0656-976X
Taipei Medical University · TWMackay Junior College of Medicine, Nursing and Management · TWTaipei Medical University Hospital · TW

Funding

Ministry of Science and Technology, Taiwan MOST 105-2314-B-038-055-MY2Ministry of Science and Technology, Taiwan MOST 106-2320-B-038-060-MY2Taipei Medical University Hospital 107IIT06Taipei Medical University-Taipei Medical University Hospital 105 TMU-TMUH-02-02
6 · The paper itself

Abstract

Thrombin is an essential procoagulant and profibrotic mediator. However, its implication in tuberculous pleural effusion (TBPE) remains unknown. The effusion thrombin and plasminogen activator inhibitor-1 (PAI-1) levels were measured among transudative pleural effusion (TPE,

Indexed as

AdultAgedAged, 80 and overAnimalsDisease Models, AnimalExudates and TransudatesFemaleFibrosisFollow-Up StudiesHumansMaleMesodermMiceMice, Inbred C57BLMiddle AgedMycobacterium tuberculosisPhosphatidylinositol 3-KinasesPlasminogen Activator Inhibitor 1Receptor, PAR-1Thrombinmesothelial–mesenchymal transitionplasminogen activator inhibitor-1pleural fibrosispleural mesothelial cellresidual pleura thickeningthrombintuberculous pleural effusiontuberculous pleural fibrosis

Identifiers

PMID31614900
PMCPMC6834128
OpenAlexW2979535234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.